$ADCT

$1.51 +$0.07 (4.86%) Close

$ADCT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$ADCT Management Team

Ms. Nicole Riley

Investor Relations

Age -

Compensation -

Sex Female

Mr. Ron Squarer

Non-Executive Chairman of the Board

Age 58

Compensation $225.5K USD

Sex Male

Mr. Ameet Mallik

Chief Executive Officer

Director

Age 52

Compensation $1.838M USD

Sex Male

Mr. Jose Carmona

Chief Financial Officer

Age 53

Compensation $933.6K USD

Sex Male

Mr. Peter Graham

Chief Legal and Compliance Officer and Secretary

Age 58

Compensation -

Sex Male

Mr. Mohamed Zaki

Chief Medical Officer

Age 60

Compensation $1.010M USD

Sex Male

Dr. Peter Hug

Non-Executive Vice Chairman of the Board

Lead Independent Director

Age 66

Compensation $227.4K USD

Sex Male

Dr. Patrick Van Berkel

Chief Scientific Officer

Age 56

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Ms. Nicole Riley Investor Relations	-	-	Female
Mr. Ron Squarer Non-Executive Chairman of the Board	58	$225.5K USD	Male
Mr. Ameet Mallik Chief Executive Officer Director	52	$1.838M USD	Male
Mr. Jose Carmona Chief Financial Officer	53	$933.6K USD	Male
Mr. Peter Graham Chief Legal and Compliance Officer and Secretary	58	-	Male
Mr. Mohamed Zaki Chief Medical Officer	60	$1.010M USD	Male
Dr. Peter Hug Non-Executive Vice Chairman of the Board Lead Independent Director	66	$227.4K USD	Male
Dr. Patrick Van Berkel Chief Scientific Officer	56	-	Male

Board of Directors

From the proxy statement filed Apr 20, 2026

Directors

serving now

Independent

7 of 9

stated in the proxy

Average tenure

4.9 years

from year joined

CEO also chairs the board

Ron Squarer

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Ameet Mallik CEO	53	2022 4 years	Not independent	None stated	None stated	Paid as CEO
Ron Squarer Board chair	59	2020 6 years	Not independent	None stated	Nuvalent Inc., Travere Therapeutics	$249,197
Robert Azelby	58	2023 3 years	Independent	Audit Committee Compensation Committee	Autolus Therapeutics, Cardinal Health, Terns Pharmaceuticals	$211,100
Jean-Pierre Bizzari	71	2022 4 years	Independent	Nomination and Corporate Governance Committee · Chair Science and Technology Committee	APREA Therapeutics, Inc.	$206,100
Timothy Coughlin	59	2025 1 year	Independent	Audit Committee · Chair	Travere Therapeutics, Inc., aTyr Pharma, Inc.	$431,129
Peter Hug Lead independent director	67	2019 7 years	Independent	Compensation Committee · Chair Nomination and Corporate Governance Committee	None stated	$250,968
Viviane Monges	62	2021 5 years	Independent	Audit Committee Nomination and Corporate Governance Committee	BioMérieux SA, Pharvaris GmBH	$246,414
Tyrell J. Rivers	53	2018 8 years	Independent	Science and Technology Committee	Cellectis S.A.	Not stated
Victor Sandor	59	2020 6 years	Independent	Compensation Committee Science and Technology Committee · Chair	Kymera Therapeutics, Inc., Prelude Therapeutics Incorporated	$211,100

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 20, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$ADCT Management Team

Ms. Nicole Riley

Mr. Ron Squarer

Mr. Ameet Mallik

Mr. Jose Carmona

Mr. Peter Graham

Mr. Mohamed Zaki

Dr. Peter Hug

Dr. Patrick Van Berkel

Board of Directors

Related-party transactions

No related-party transactions disclosed